Examining stroke prevention and bleeding risk in subclinical atrial fibrillation, including the NOAH-AFNET 6 Trial November 27, 2023 Summary: ARTESiA Late-Breaking Clinical Trial presented at AHA showed that apixaban was better than aspirin at preventing strokes in device-detected subclinical afib lasting 6 minutes to 24 hours. Reading time: 3–4 minutes This month, the results from …
Read More
AZALEA Trial: Potential of abelacimab for stroke protection without bleeding risk November 27, 2023 Summary: Results of the late-breaking AZALEA Trial presented at AHA showed the potential of abelacimab for providing stroke protection without bleeding risk. Reading time: 3–4 minutes This month, the Afib Late-Breaking Clinical Trials session at the American Heart Association Scientific Sessions …
Read More
Medicare Wants to Understand Patient Experiences with Anticoagulants (Blood Thinners) October 11, 2023 Summary: Make your voice heard! Please take our survey to inform our comments to Medicare about anticoagulants (blood thinners). Reading time: 2–3 minutes Medicare recently announced that it will negotiate the prices of two afib drugs, Eliquis and Xarelto. As CMS (Center …
Read More
Afib Awareness Month Webinars Hosted by Medtronic September 11, 2023 For National Atrial Fibrillation Awareness Month, I’m excited to moderate two afib webinars being hosted by Medtronic. Tuesday, September 26, 2023 at 5:00 p.m. PT | 6:00 p.m. MT | 7:00 p.m. CT | 8:00 p.m. ETJoin a discussion with Dr. Devi Nair, Director, Cardiac …
Read More
August 31, 2023 Summary: The VIBRANT-AF Study will improve the effectiveness of catheter ablation Reading time: 2 minutes Do you plan to have an atrial fibrillation (afib) catheter ablation? By joining the VIBRANT-AF Study before your catheter ablation, you can contribute your data to an effectiveness study that will improve the care of afib patients having …
Read More
July 5, 2023 Summary: Your input led to an ISTH presentation about the new concept of Patient-Relevant Bleeding Reading time: 2–3 minutes On June 25, 2023, Anthos Therapeutics, in collaboration with two internationally recognized patient advocacy groups, StopAfib.org and the National Blood Clot Alliance (NBCA), presented new data from a survey of patients about the …
Read More
When you join us at this year’s Get in Rhythm. Stay in Rhythm.® Atrial Fibrillation Patient Conference August 4–6 in Dallas, you’ll have the opportunity to hear from two renowned afib authors—both first-time faculty members with us. We’re thrilled to announce that Dr. Jared Bunch, co-author of The Afib Cure: Get Off Your Medications, Take …
Read More
February 24, 2023 Summary: Basketball Legend Kareem Abdul-Jabbar Shares His AFib Diagnosis Story Reading time: 3–4 minutes Kareem Abdul-Jabbar has teamed up with Bristol Myers Squibb and Pfizer to share his atrial fibrillation (AFib) diagnosis story as part of the No Time to Wait campaign. Like many other AFib patients, Kareem knows how easy it can …
Read More
February 20, 2023 UPDATED: August 30, 2023 Summary: Access patient tools to help in making a decision about taking blood thinners. Reading time: 3–4 minutes Some new tools are available for use in making a decision about whether to take blood thinners. These tools come from the ENHANCE-AF (Engaging Patients to Help Achieve Increased Patient …
Read More
December 12, 2022Applications close December 20, 2022 at 5pm Central Time. Summary: Reading time: 3–4 minutes StopAfib.org is seeking afib patients interested in participating in an advocacy training program. The training will help prepare individuals to share patient perspectives with various audiences and participate in advocacy activities on behalf of StopAfib.org. Upon completion of the …
Read More